Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol. 2014;15(11):703–8.
Article
CAS
PubMed
Google Scholar
Lawrence M, Daujat S, Schneider R. Lateral thinking: how histone modifications regulate gene expression. Trends Genet. 2016;32(1):42–56.
Article
CAS
PubMed
Google Scholar
Sen N. Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction. Neuromol Med. 2015;17(2):97–110.
Article
CAS
Google Scholar
Muller S, Filippakopoulos P, Knapp S. Bromodomains as therapeutic targets. Expert Rev Mol Med. 2011;13:e29.
Article
PubMed
PubMed Central
Google Scholar
Johansson C, Tumber A, Che K, Cain P, Nowak R, Gileadi C, Oppermann U. The roles of Jumonji-type oxygenases in human disease. Epigenomics. 2014;6(1):89–120.
Article
CAS
PubMed
PubMed Central
Google Scholar
McAllister TE, England KS, Hopkinson RJ, Brennan PE, Kawamura A, Schofield CJ. Recent progress in histone demethylase inhibitors. J Med Chem. 2016;59(4):1308–29.
Article
CAS
PubMed
Google Scholar
Dimitrova E, Turberfield AH, Klose RJ. Histone demethylases in chromatin biology and beyond. EMBO Rep. 2015;16(12):1620–39.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang T, Cooper S, Brockdorff N. The interplay of histone modifications—writers that read. EMBO Rep. 2015;16(11):1467–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muller S, Brown PJ. Epigenetic chemical probes. Clin Pharmacol Ther. 2012;92(6):689–93.
Article
CAS
PubMed
Google Scholar
Maes T, Carceller E, Salas J, Ortega A, Buesa C. Advances in the development of histone lysine demethylase inhibitors. Curr Opin Pharmacol. 2015;23:52–60.
Article
CAS
PubMed
Google Scholar
Bavetsias V, Lanigan RM, Ruda GF, Atrash B, McLaughlin MG, Tumber A, Mok NY, Le Bihan YV, Dempster S, Boxall KJ, et al. 8-Substituted pyrido[3,4-d]pyrimidin-4(3H)-one derivatives as potent, cell permeable, KDM4 (JMJD2) and KDM5 (JARID1) histone lysine demethylase inhibitors. J Med Chem. 2016;59(4):1388–409.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thinnes CC, Tumber A, Yapp C, Scozzafava G, Yeh T, Chan MC, Tran TA, Hsu K, Tarhonskaya H, Walport LJ, et al. Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases. Chem Commun (Camb). 2015;51(84):15458–61.
Article
CAS
Google Scholar
Westaway SM, Preston AG, Barker MD, Brown F, Brown JA, Campbell M, Chung CW, Drewes G, Eagle R, Garton N, et al. Cell penetrant inhibitors of the KDM4 and KDM5 families of histone lysine demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one derivatives. J Med Chem. 2016;59(4):1370–87.
Article
CAS
PubMed
Google Scholar
Westaway SM, Preston AG, Barker MD, Brown F, Brown JA, Campbell M, Chung CW, Diallo H, Douault C, Drewes G, et al. Cell penetrant inhibitors of the KDM4 and KDM5 families of histone lysine demethylases. 1. 3-Amino-4-pyridine carboxylate derivatives. J Med Chem. 2016;59(4):1357–69.
Article
CAS
PubMed
Google Scholar
McGrath J, Trojer P. Targeting histone lysine methylation in cancer. Pharmacol Ther. 2015;150:1–22.
Article
CAS
PubMed
Google Scholar
Wang L, Chang J, Varghese D, Dellinger M, Kumar S, Best AM, Ruiz J, Bruick R, Pena-Llopis S, Xu J, et al. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat Commun. 2013;4:2035.
PubMed
PubMed Central
Google Scholar
Liang J, Zhang B, Labadie S, Ortwine DF, Vinogradova M, Kiefer JR, Gehling VS, Harmange JC, Cummings R, Lai T, et al. Lead optimization of a pyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies. Bioorg Med Chem Lett. 2016;26(16):4036–41.
Article
CAS
PubMed
Google Scholar
Torres IO, Kuchenbecker KM, Nnadi CI, Fletterick RJ, Kelly MJ, Fujimori DG. Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism. Nat Commun. 2015;6:6204.
Article
CAS
PubMed
PubMed Central
Google Scholar
Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y, Cheng X. Enzymatic and structural insights for substrate specificity of a family of Jumonji histone lysine demethylases. Nat Struct Mol Biol. 2010;17(1):38–43.
Article
CAS
PubMed
Google Scholar
Martinez NJ, Simeonov A. Cell-based assays to support the profiling of small molecules with histone methyltransferase and demethylase modulatory activity. Drug Discov Today Technol. 2015;18:9–17.
Article
PubMed
PubMed Central
Google Scholar
Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, et al. A selective Jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012;488(7411):404–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Itoh Y, Sawada H, Suzuki M, Tojo T, Sasaki R, Hasegawa M, Mizukami T, Suzuki T. Identification of Jumonji AT-rich interactive domain 1A inhibitors and their effect on cancer cells. ACS Med Chem Lett. 2015;6(6):665–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schiller R, Scozzafava G, Tumber A, Wickens JR, Bush JT, Rai G, Lejeune C, Choi H, Yeh TL, Chan MC, et al. A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1. ChemMedChem. 2014;9(3):566–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Labelle M, Boesen T, Mehrotra M, Khan Q, Ullah F. Inhibitors of histone demethylases. International Patent WO2014053491A1, 2014.
Johansson C, Velupillai S, Tumber A, Szykowska A, Hookway ES, Nowak RP, Strain-Damerell C, Gileadi C, Philpott M, Burgess-Brown N, et al. Structural analysis of human KDM5B guides histone demethylase inhibitor development. Nat Chem Biol. 2016;12:539–45.
Article
CAS
PubMed
Google Scholar
Horton JR, Engstrom A, Zoeller EL, Liu X, Shanks JR, Zhang X, Johns MA, Vertino PM, Fu H, Cheng X. Characterization of a linked Jumonji domain of the KDM5/JARID1 family of histone H3 lysine 4 demethylases. J Biol Chem. 2016;291(6):2631–46.
Article
CAS
PubMed
Google Scholar
Luo X, Liu Y, Kubicek S, Myllyharju J, Tumber A, Ng S, Che KH, Podoll J, Heightman TD, Oppermann U, et al. A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases. J Am Chem Soc. 2011;133(24):9451–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vinogradova M, Gehling VS, Gustafson A, Arora S, Tindell CA, Wilson C, Williamson KE, Guler GD, Gangurde P, Manieri W, et al. An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. Nat Chem Biol. 2016;12(7):531–8.
Article
CAS
PubMed
Google Scholar
Gehling VS, Bellon SF, Harmange JC, LeBlanc Y, Poy F, Odate S, Buker S, Lan F, Arora S, Williamson KE, et al. Identification of potent, selective KDM5 inhibitors. Bioorg Med Chem Lett. 2016;26(17):4350–4.
Article
CAS
PubMed
Google Scholar
Hopkinson RJ, Tumber A, Yapp C, Chowdhury R, Aik W, Che KH, Li XS, Kristensen JB, King ON, Chan MC, et al. 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation. Chem Sci. 2013;4(8):3110–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heinemann B, Nielsen JM, Hudlebusch HR, Lees MJ, Larsen DV, Boesen T, Labelle M, Gerlach LO, Birk P, Helin K. Inhibition of demethylases by GSK-J1/J4. Nature. 2014;514(7520):E1–2.
Article
CAS
PubMed
Google Scholar
Montenegro RC, Clark PG, Howarth A, Wan X, Ceroni A, Siejka P, Nunez-Alonso GA, Monteiro O, Rogers C, Gamble V, et al. BET inhibition as a new strategy for the treatment of gastric cancer. Oncotarget. 2016;7(28):43997–4012.
PubMed
PubMed Central
Google Scholar
Joberty G, Boesche M, Brown JA, Eberhard D, Garton NS, Mathieson T, Muelbaier M, Ramsden NG, Reader V, Rueger A, et al. Interrogating the druggability of the 2-oxoglutarate-dependent dioxygenase target class by chemical proteomics. ACS Chem Biol. 2016;11(7):2002–10.
Article
CAS
PubMed
Google Scholar
Lillico R, Sobral MG, Stesco N, Lakowski TM. HDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylases. J Proteom. 2016;133:125–33.
Article
CAS
Google Scholar
Cheng MF, Lee CH, Hsia KT, Huang GS, Lee HS. Methylation of histone H3 lysine 27 associated with apoptosis in osteosarcoma cells induced by staurosporine. Histol Histopathol. 2009;24(9):1105–11.
CAS
PubMed
Google Scholar
Allera C, Lazzarini G, Patrone E, Alberti I, Barboro P, Sanna P, Melchiori A, Parodi S, Balbi C. The condensation of chromatin in apoptotic thymocytes shows a specific structural change. J Biol Chem. 1997;272(16):10817–22.
Article
CAS
PubMed
Google Scholar
Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191–5.
Article
CAS
PubMed
Google Scholar
Walter D, Matter A, Fahrenkrog B. Loss of histone H3 methylation at lysine 4 triggers apoptosis in Saccharomyces cerevisiae. PLoS Genet. 2014;10(1):e1004095.
Article
PubMed
PubMed Central
Google Scholar
Pang B, Qiao X, Janssen L, Velds A, Groothuis T, Kerkhoven R, Nieuwland M, Ovaa H, Rottenberg S, van Tellingen O, et al. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun. 2013;4:1908.
Article
PubMed
PubMed Central
Google Scholar
Lambert JP, Tucholska M, Pawson T, Gingras AC. Incorporating DNA shearing in standard affinity purification allows simultaneous identification of both soluble and chromatin-bound interaction partners. J Proteom. 2014;100:55–9.
Article
CAS
Google Scholar